Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this pre-approval access program is to provide talquetamab for the treatment of participants with relapsed or refractory multiple myeloma.
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal